René Rodriguez

17PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 12, 2026
Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma.

|May 28, 2025
Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182.

Megan Fife, Ming Tong, Bhaskar Das

|Jun 08, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Nadia Mensali, Hakan Köksal, Sandy Joaquina

|Jan 21, 2023
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer.

Dzohara Murillo, Carmen Huergo, Borja Gallego

|Jun 24, 2022
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models.

Borja Gallego, Dzohara Murillo, Verónica Rey

|Apr 28, 2022
Proof of concept for the use of trained sniffer dogs to detect osteosarcoma.

Agustín Ortal, Aida Rodríguez, María Pilar Solis-Hernández

Pageof 3

Frequent Collaborators

4 joint publications

Juana M García-Pedrero

4 joint publications

Juana M García-Pedrero

3 joint publications

Juan Tornín

3 joint publications

Francisco Hermida-Prado